Form 4: ProKidney Corp. Director Jimenez Santos Jose Ignacio Acquires Stock Options
SEC Form 4 Filing
Director Jimenez Santos Jose Ignacio acquired 62,558 stock options in ProKidney Corp. on May 30, 2024.
Summary
- On May 30, 2024, Jimenez Santos Jose Ignacio, a director of ProKidney Corp., acquired 62,558 stock options.
- The options were granted under the Issuer's non-employee director compensation policy.
- The exercise price of the options is $4.2.
- The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting.
- The options expire on May 30, 2034.
Sentiment
Score: 6
Explanation: The document is a routine filing related to director compensation, indicating standard corporate governance practices. It doesn't contain any particularly positive or negative news.
Positives
- The grant of stock options to a director aligns their interests with those of the shareholders.
Industry Context
This is a standard practice for compensating directors of publicly traded companies.
Stakeholder Impact
- The granting of stock options aligns the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/30/2024 | Date of the transaction: Jimenez Santos Jose Ignacio acquired 62,558 stock options. |
| 05/30/2034 | Expiration date of the stock options. |
| 06/03/2024 | Date of the signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.